{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:51:17Z","timestamp":1791996677525,"version":"4.4.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"am","delay-in-days":379,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23HL143053"],"award-info":[{"award-number":["K23HL143053"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ccm.2022.05.003","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T18:04:35Z","timestamp":1663265075000},"page":"489-498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Advances in Sepsis Care"],"prefix":"10.1016","volume":"43","author":[{"given":"Karen E.","family":"Jackson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew W.","family":"Semler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ccm.2022.05.003_bib1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"10219","key":"10.1016\/j.ccm.2022.05.003_bib2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"The Lancet"},{"issue":"4","key":"10.1016\/j.ccm.2022.05.003_bib3","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS international sepsis definitions conference","volume":"31","author":"Levy","year":"2003","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.ccm.2022.05.003_bib4","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock\u2217","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit Care Med"},{"issue":"8","key":"10.1016\/j.ccm.2022.05.003_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/CCM.0000000000000330","article-title":"Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program","volume":"42","author":"Ferrer","year":"2014","journal-title":"Crit Care Med"},{"issue":"23","key":"10.1016\/j.ccm.2022.05.003_bib6","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa1703058","article-title":"Time to treatment and mortality during mandated emergency care for sepsis","volume":"376","author":"Seymour","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ccm.2022.05.003_bib7","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/jama.2018.9071","article-title":"Association between the New York sepsis care mandate and in-hospital mortality for pediatric sepsis","volume":"320","author":"Evans","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ccm.2022.05.003_bib8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S2213-2600(17)30469-1","article-title":"Prehospital antibiotics in the ambulance for sepsis: a multicentre, open label, randomised trial","volume":"6","author":"Alam","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.ccm.2022.05.003_bib9","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock","volume":"45","author":"Rhodes","year":"2017","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.ccm.2022.05.003_bib10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1060028019877937","article-title":"Time to first culture positivity among critically ill adults with methicillin-resistant staphylococcus aureus growth in respiratory or blood cultures","volume":"54","author":"Melling","year":"2020","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.ccm.2022.05.003_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/0885066620963903","article-title":"Time to first culture positivity for gram-negative rods resistant to ceftriaxone in critically ill adults","volume":"36","author":"Buell","year":"2021","journal-title":"J\u00a0Intensive Care Med"},{"key":"10.1016\/j.ccm.2022.05.003_bib12","first-page":"1","article-title":"Evaluation of verigene blood culture test systems for rapid identification of positive blood cultures","volume":"2016","author":"Kim","year":"2016","journal-title":"Biomed Res Int"},{"issue":"14","key":"10.1016\/j.ccm.2022.05.003_bib13","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1001\/jama.2014.12923","article-title":"Prevalence of antimicrobial use in us acute care hospitals, May-September 2011","volume":"312","author":"Magill","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ccm.2022.05.003_bib14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.12788\/jhm.2684","article-title":"Acute kidney injury in patients treated with vancomycin and piperacillin-tazobactam: a retrospective cohort analysis","volume":"12","author":"Rutter","year":"2017","journal-title":"J\u00a0Hosp Med"},{"issue":"4","key":"10.1016\/j.ccm.2022.05.003_bib15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.annemergmed.2018.06.004","article-title":"Are patients receiving the combination of vancomycin and piperacillin-tazobactam at higher risk for acute renal injury?","volume":"72","author":"Long","year":"2018","journal-title":"Ann Emerg Med"},{"issue":"5","key":"10.1016\/j.ccm.2022.05.003_bib16","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ijantimicag.2018.08.001","article-title":"Comparative incidence and excess risk of acute kidney injury in hospitalised patients receiving vancomycin and piperacillin\/tazobactam in combination or as monotherapy","volume":"52","author":"Carreno","year":"2018","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"10.1016\/j.ccm.2022.05.003_bib17","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.cmi.2020.03.019","article-title":"Acute kidney injury following the concurrent administration of antipseudomonal \u03b2-lactams and vancomycin: a network meta-analysis","volume":"26","author":"Bellos","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.ccm.2022.05.003_bib18","doi-asserted-by":"crossref","first-page":"106010","DOI":"10.1016\/j.ijantimicag.2020.106010","article-title":"Acute kidney injury with combination vancomycin and piperacillin-tazobactam therapy in the ICU: a retrospective cohort study","volume":"56","author":"O\u2019Callaghan","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.ccm.2022.05.003_bib19","doi-asserted-by":"crossref","first-page":"ofx170","DOI":"10.1093\/ofid\/ofx170","article-title":"Characterizing cefepime neurotoxicity: a systematic review","volume":"4","author":"Appa","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.ccm.2022.05.003_bib20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cmi.2019.06.028","article-title":"Cefepime neurotoxicity: thresholds and risk factors. A retrospective cohort study","volume":"26","author":"Boschung-Pasquier","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"10.1016\/j.ccm.2022.05.003_bib21","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock","volume":"369","author":"Angus","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ccm.2022.05.003_bib22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.annemergmed.2018.03.039","article-title":"Liberal versus restrictive intravenous fluid therapy for early septic shock: rationale for a randomized trial","volume":"72","author":"Self","year":"2018","journal-title":"Ann Emerg Med"},{"issue":"1","key":"10.1016\/j.ccm.2022.05.003_bib23","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13613-018-0402-x","article-title":"Principles of fluid management and stewardship in septic shock: it is time to consider the four D\u2019s and the four phases of fluid therapy","volume":"8","author":"Malbrain","year":"2018","journal-title":"Ann Intensive Care"},{"issue":"19","key":"10.1016\/j.ccm.2022.05.003_bib24","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJMoa010307","article-title":"Early goal-directed therapy in the treatment of severe sepsis and septic shock","volume":"345","author":"Rivers","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.ccm.2022.05.003_bib25","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1056\/NEJMoa1401602","article-title":"A\u00a0randomized trial of protocol-based care for early septic shock","volume":"370","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.ccm.2022.05.003_bib26","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1056\/NEJMoa1404380","article-title":"Goal-directed resuscitation for patients with early septic shock","volume":"371","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"10.1016\/j.ccm.2022.05.003_bib27","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJMoa1500896","article-title":"Trial of early, goal-directed resuscitation for septic shock","volume":"372","author":"Mouncey","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.ccm.2022.05.003_bib28","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1056\/NEJMoa1701380","article-title":"Early, goal-directed therapy for septic shock \u2014 a patient-level meta-analysis","volume":"376","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.ccm.2022.05.003_bib29","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.2017.10913","article-title":"Effect of an early resuscitation protocol on in-hospital mortality among adults with sepsis and hypotension: a randomized clinical trial","volume":"318","author":"Andrews","year":"2017","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.ccm.2022.05.003_bib30","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1097\/CCM.0000000000000541","article-title":"Simplified severe sepsis protocol: a randomized controlled trial of modified early goal\u2013directed therapy in Zambia\u2217","volume":"42","author":"Andrews","year":"2014","journal-title":"Crit Care Med"},{"issue":"26","key":"10.1016\/j.ccm.2022.05.003_bib31","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa1101549","article-title":"Mortality after fluid bolus in african children with severe infection","volume":"364","author":"Maitland","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccm.2022.05.003_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.annemergmed.2021.02.006","article-title":"Early care of adults with suspected sepsis in the emergency department and out-of-hospital environment: a consensus-based task force report","author":"Yealy","year":"2021","journal-title":"Ann Emerg Med"},{"issue":"9","key":"10.1016\/j.ccm.2022.05.003_bib33","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/jhm.2394","article-title":"Safety of peripheral intravenous administration of vasoactive medication: peripheral Administration of VM","volume":"10","author":"Cardenas-Garcia","year":"2015","journal-title":"J\u00a0Hosp Med"},{"issue":"5","key":"10.1016\/j.ccm.2022.05.003_bib34","doi-asserted-by":"crossref","first-page":"e0176292","DOI":"10.1371\/journal.pone.0176292","article-title":"Patterns of intravenous fluid resuscitation use in adult intensive care patients between 2007 and 2014: an international cross-sectional study","volume":"12","author":"Hammond","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ccm.2022.05.003_bib35","doi-asserted-by":"crossref","first-page":"e010041","DOI":"10.1136\/bmjopen-2015-010041","article-title":"Multicountry survey of emergency and critical care medicine physicians\u2019 fluid resuscitation practices for adult patients with early septic shock","volume":"6","author":"McIntyre","year":"2016","journal-title":"BMJ Open"},{"issue":"16","key":"10.1016\/j.ccm.2022.05.003_bib36","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.2015.12334","article-title":"Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit: the SPLIT randomized clinical trial","volume":"314","author":"Young","year":"2015","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.ccm.2022.05.003_bib37","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1164\/rccm.201607-1345OC","article-title":"Balanced crystalloids versus saline in the intensive care unit. the SALT randomized trial","volume":"195","author":"Semler","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.ccm.2022.05.003_bib38","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1711584","article-title":"Balanced crystalloids versus saline in critically ill adults","volume":"378","author":"Semler","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.ccm.2022.05.003_bib39","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1711586","article-title":"Balanced crystalloids versus saline in Noncritically ill adults","volume":"378","author":"Self","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccm.2022.05.003_bib40","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201903-0557OC","article-title":"Balanced crystalloids versus saline in sepsis: a secondary analysis of the SMART trial","author":"Brown","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2022.05.003_bib41","article-title":"Effect of early balanced crystalloids before ICU admission on sepsis outcomes","author":"Jackson","year":"2020","journal-title":"Chest"},{"issue":"22","key":"10.1016\/j.ccm.2022.05.003_bib42","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa040232","article-title":"A comparison of albumin and saline for fluid resuscitation in the intensive care unit","volume":"350","author":"Finfer","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1016\/j.ccm.2022.05.003_bib43","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa1305727","article-title":"Albumin replacement in patients with severe sepsis or septic shock","volume":"370","author":"Caironi","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ccm.2022.05.003_bib44","doi-asserted-by":"crossref","first-page":"347","DOI":"10.7326\/M14-0178","article-title":"Fluid resuscitation in sepsis: a systematic review and network meta-analysis","volume":"161","author":"Rochwerg","year":"2014","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.ccm.2022.05.003_bib45","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2174\/15748863113089990046","article-title":"Relative survival benefit and morbidity with fluids in severe sepsis - a network meta-analysis of alternative therapies","volume":"8","author":"Bansal","year":"2013","journal-title":"Curr Drug Saf"},{"issue":"2","key":"10.1016\/j.ccm.2022.05.003_bib46","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa070716","article-title":"Intensive insulin therapy and pentastarch resuscitation in severe sepsis","volume":"358","author":"Brunkhorst","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ccm.2022.05.003_bib47","doi-asserted-by":"crossref","first-page":"R94","DOI":"10.1186\/11358","article-title":"Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130\/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study","volume":"16","author":"Guidet","year":"2012","journal-title":"Crit Care"},{"issue":"20","key":"10.1016\/j.ccm.2022.05.003_bib48","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1056\/NEJMoa1209759","article-title":"Hydroxyethyl starch or saline for fluid resuscitation in intensive care","volume":"367","author":"Myburgh","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ccm.2022.05.003_bib49","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1056\/NEJMoa1204242","article-title":"Hydroxyethyl starch 130\/0.42 versus ringer\u2019s acetate in severe sepsis","volume":"367","author":"Perner","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.ccm.2022.05.003_bib50","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ccm.2022.05.003_bib51","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jemermed.2012.04.084","article-title":"Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis","volume":"42","author":"Melzer","year":"2012","journal-title":"J\u00a0Emerg Med"},{"issue":"9","key":"10.1016\/j.ccm.2022.05.003_bib52","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock","volume":"358","author":"Russell","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ccm.2022.05.003_bib53","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00134-009-1687-x","article-title":"The effects of vasopressin on acute kidney injury in septic shock","volume":"36","author":"Gordon","year":"2010","journal-title":"Intensive Care Med"},{"issue":"5","key":"10.1016\/j.ccm.2022.05.003_bib54","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jama.2016.10485","article-title":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial","volume":"316","author":"Gordon","year":"2016","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.ccm.2022.05.003_bib55","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1007\/s00134-018-5267-9","article-title":"Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial","volume":"44","author":"Study Group of Investigators","year":"2018","journal-title":"Intensive Care Med"},{"issue":"15","key":"10.1016\/j.ccm.2022.05.003_bib56","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1001\/jama.2019.14607","article-title":"Effect of selepressin vs Placebo on ventilator- and vasopressor-free days in patients with septic shock: the SEPSIS-ACT randomized clinical trial","volume":"322","author":"Laterre","year":"2019","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ccm.2022.05.003_bib57","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s13054-014-0534-9","article-title":"Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study","volume":"18","author":"Chawla","year":"2014","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.ccm.2022.05.003_bib58","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ccm.2022.05.003_bib59","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1164\/rccm.201011-1897CI","article-title":"Systemic steroids in severe sepsis and septic shock","volume":"185","author":"Patel","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.ccm.2022.05.003_bib60","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00000658-197609000-00011","article-title":"Steroids in the treatment of clinical septic shock","volume":"184","author":"Schumer","year":"1976","journal-title":"Ann Surg"},{"issue":"7","key":"10.1016\/j.ccm.2022.05.003_bib61","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jama.288.7.862","article-title":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock","volume":"288","author":"Annane","year":"2002","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ccm.2022.05.003_bib62","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa071366","article-title":"Hydrocortisone therapy for patients with septic shock","volume":"358","author":"Sprung","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.ccm.2022.05.003_bib63","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1705835","article-title":"Adjunctive glucocorticoid therapy in patients with septic shock","volume":"378","author":"Venkatesh","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.ccm.2022.05.003_bib64","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone plus fludrocortisone for adults with septic shock","volume":"378","author":"Annane","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.ccm.2022.05.003_bib65","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1001\/jama.2016.5828","article-title":"Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial","volume":"315","author":"Zarbock","year":"2016","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ccm.2022.05.003_bib66","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa1603017","article-title":"Initiation strategies for renal-replacement therapy in the intensive care unit","volume":"375","author":"Gaudry","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ccm.2022.05.003_bib67","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1056\/NEJMoa2000741","article-title":"Timing of initiation of renal-replacement therapy in acute kidney injury","volume":"383","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1016\/j.ccm.2022.05.003_bib68","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJMoa1803213","article-title":"Timing of renal-replacement therapy in patients with acute kidney injury and sepsis","volume":"379","author":"Barbar","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ccm.2022.05.003_bib69","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1097\/CCM.0b013e3182120cb8","article-title":"Ascorbic acid attenuates lipopolysaccharide-induced acute lung injury\u2217","volume":"39","author":"Fisher","year":"2011","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccm.2022.05.003_bib70","doi-asserted-by":"crossref","first-page":"L20","DOI":"10.1152\/ajplung.00300.2011","article-title":"Mechanisms of attenuation of abdominal sepsis induced acute lung injury by ascorbic acid","volume":"303","author":"Fisher","year":"2012","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"10.1016\/j.ccm.2022.05.003_bib71","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1479-5876-12-32","article-title":"Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis","volume":"12","author":"Fowler","year":"2014","journal-title":"J\u00a0Transl Med"},{"issue":"13","key":"10.1016\/j.ccm.2022.05.003_bib72","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.11825","article-title":"Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI randomized clinical trial","volume":"322","author":"Fowler","year":"2019","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ccm.2022.05.003_bib73","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1001\/jama.2019.22176","article-title":"Effect of vitamin C, hydrocortisone, and thiamine vs hydrocortisone alone on time alive and free of vasopressor support among patients with septic shock: the VITAMINS randomized clinical trial","volume":"323","author":"Fujii","year":"2020","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.ccm.2022.05.003_bib74","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/jama.2020.24505","article-title":"Effect of vitamin C, thiamine, and hydrocortisone on ventilator- and vasopressor-free days in patients with sepsis: the VICTAS randomized clinical trial","volume":"325","author":"Sevransky","year":"2021","journal-title":"JAMA"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523122000387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523122000387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:16:30Z","timestamp":1759454190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523122000387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0272523122000387"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2022.05.003","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in Sepsis Care","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2022.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}